Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1979 Nov;190(5):595–608. doi: 10.1097/00000658-197911000-00007

Thrombotic complications of heparin therapy: including six cases of heparin--induced skin necrosis.

P W White, J R Sadd, R E Nensel
PMCID: PMC1344538  PMID: 507970

Abstract

Thrombotic complications of heparin administration were observed in eight patients during a two year period. At sites of subcutaneous heparin injection, six patients developed areas of the skin and subcutaneous necrosis. Systemic thrombotic events and thrombocytopenia were observed in two of these patients when they received intravenous heparin and in two other patients who did not have primary skin necrosis. The complications included peripheral ischemia in three patients (two requiring amputation), myocardial infarction in two, and a cerebral infarction in one. All patients were receiving heparin for at least six days before complications occurred. Seven patients received heparin of bovine origin. Heparin-induced in vitro platelet aggregation was present in all six of the eight patients tested. (It was marked in four of these patients). It is theorized that skin necrosis and the other thrombotic complications observed are the result of heparin-induced in vivo platelet aggregation followed by intravascular thrombosis. Heparin-induced skin necrosis is a rare but serious hazard encountered with prophylactic heparin regimens. If heparin-induced thrombosis is present, the further use of heparin is contraindicated in most instances.

Full text

PDF
595

Images in this article

597Fig. 1.
on p.597

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERNSTEIN I. L. Anaphylaxis to heparin sodium; report of a case, with immunologic studies. J Am Med Assoc. 1956 Aug 4;161(14):1379–1381. doi: 10.1001/jama.1956.62970140005009b. [DOI] [PubMed] [Google Scholar]
  2. Babcock R. B., Dumper C. W., Scharfman W. B. Heparin-induced immune thrombocytopenia. N Engl J Med. 1976 Jul 29;295(5):237–241. doi: 10.1056/NEJM197607292950501. [DOI] [PubMed] [Google Scholar]
  3. Baird R. A., Convery R. Arterial thromboembolism in patients receiving systemic heparin therapy: a complication associated with heparin-induced thrombocytopenia. J Bone Joint Surg Am. 1977 Dec;59(8):1061–1064. [PubMed] [Google Scholar]
  4. Barker C. F., Rosato F. E., Roberts B. Peripheral arterial embolism. Surg Gynecol Obstet. 1966 Jul;123(1):22–26. [PubMed] [Google Scholar]
  5. Bell W. R., Tomasulo P. A., Alving B. M., Duffy T. P. Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients. Ann Intern Med. 1976 Aug;85(2):155–160. doi: 10.7326/0003-4819-85-2-155. [DOI] [PubMed] [Google Scholar]
  6. Besterman E. M., Gillett M. P. Heparin effects on plasma lysolecithin formation and platelet aggregation. Atherosclerosis. 1973 May-Jun;17(3):503–513. doi: 10.1016/0021-9150(73)90040-3. [DOI] [PubMed] [Google Scholar]
  7. Bridges J. M., Dalby A. M., Hadden D. R., Johnston H. A., Weaver J. A. The effect of "in vivo" alteration of free fatty acids on platelet stickiness. J Atheroscler Res. 1967 Sep-Oct;7(5):695–699. doi: 10.1016/s0368-1319(67)80045-0. [DOI] [PubMed] [Google Scholar]
  8. Connor W. E. THE ACCELERATION OF THROMBUS FORMATION BY CERTAIN FATTY ACIDS. J Clin Invest. 1962 Jun;41(6):1199–1205. doi: 10.1172/JCI104580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Curry N., Bardana E. J., Pirofsky B. Heparin sensitivity. Report of a case. Arch Intern Med. 1973 Nov;132(5):744–745. [PubMed] [Google Scholar]
  10. Eika C. Inhibition of thrombin induced aggregation of human platelets by heparin. Scand J Haematol. 1971;8(3):216–222. doi: 10.1111/j.1600-0609.1971.tb01976.x. [DOI] [PubMed] [Google Scholar]
  11. Eika C. On the mechanism of platelet aggregation induced by heparin, protamine and polybrene. Scand J Haematol. 1972;9(3):248–257. doi: 10.1111/j.1600-0609.1972.tb00937.x. [DOI] [PubMed] [Google Scholar]
  12. Eika C. The platelet aggregating effect of eight commercial heparins. Scand J Haematol. 1972;9(5):480–482. doi: 10.1111/j.1600-0609.1972.tb00973.x. [DOI] [PubMed] [Google Scholar]
  13. Faraci P. A., Deterling R. A., Jr, Stein A. M., Rheinlander H. F., Cleveland R. J. Warfarin induced necrosis of the skin. Surg Gynecol Obstet. 1978 May;146(5):695–700. [PubMed] [Google Scholar]
  14. Fratantoni J. C., Pollet R., Gralnick H. R. Heparin-induced thrombocytopenia: confirmation of diagnosis with in vitro methods. Blood. 1975 Mar;45(3):395–401. [PubMed] [Google Scholar]
  15. GOLLUB S., ULIN A. W. Heparin-induced thrombocytopenia in man. J Lab Clin Med. 1962 Mar;59:430–435. [PubMed] [Google Scholar]
  16. Gröttum K. A. Platelet surface charge and aggregation. Effects of polyelectrolytes. Thromb Diath Haemorrh. 1969 Jun 15;21(3):450–462. [PubMed] [Google Scholar]
  17. HAUCH E. W., CARRYER H. M., MATHIESON D. R. Hypersensitivity to heparin: report of 3 cases. Proc Staff Meet Mayo Clin. 1952 Apr 9;27(8):163–166. [PubMed] [Google Scholar]
  18. Han P., Ardlie N. G. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis. Br J Haematol. 1974 Jun;27(2):253–272. doi: 10.1111/j.1365-2141.1974.tb06792.x. [DOI] [PubMed] [Google Scholar]
  19. Hill J., Caprini J. A., Robbins J. L. An unusual complication of minidose heparin therapy. Clin Orthop Relat Res. 1976 Jul-Aug;(118):130–132. [PubMed] [Google Scholar]
  20. Hume M., Smith-Petersen M., Fremont-Smith P. Letter: Sensitivity to intrafat heparin. Lancet. 1974 Feb 16;1(7851):261–261. doi: 10.1016/s0140-6736(74)92561-6. [DOI] [PubMed] [Google Scholar]
  21. KINGERY F. A. COLD URTICARIA. JAMA. 1965 Apr 12;192:107–107. doi: 10.1001/jama.1965.03080150037006. [DOI] [PubMed] [Google Scholar]
  22. Kakkar V. V. The current status of low-dose heparin in the prophylaxis of thrombophlebitis and pulmonary embolism. World J Surg. 1978 Jan;2(1):3–18. doi: 10.1007/BF01574449. [DOI] [PubMed] [Google Scholar]
  23. Klein H. G., Bell W. R. Disseminated intravascular coagulation during heparin therapy. Ann Intern Med. 1974 Apr;80(4):477–481. doi: 10.7326/0003-4819-80-4-477. [DOI] [PubMed] [Google Scholar]
  24. Koch-Weser J. Coumarin necrosis. Ann Intern Med. 1968 Jun;68(6):1365–1367. doi: 10.7326/0003-4819-68-6-1365. [DOI] [PubMed] [Google Scholar]
  25. Kongtahworn C., Foster E., Mason E. E., Printen K. J. Heparin-induced elevation of free fatty acids in diabetic patients. Surgery. 1973 Jul;74(1):30–33. [PubMed] [Google Scholar]
  26. Law I. P., Knight H. Jaundice associated with naproxen. N Engl J Med. 1976 Nov 18;295(21):1201–1201. doi: 10.1056/NEJM197611182952119. [DOI] [PubMed] [Google Scholar]
  27. MUSTARD J. F., MURPHY E. A., ROWSELL H. C., DOWNIE H. G. Factors influencing thrombus formation in vivo. Am J Med. 1962 Nov;33:621–647. doi: 10.1016/0002-9343(62)90243-7. [DOI] [PubMed] [Google Scholar]
  28. Malcolm I. D., Wigmore T. A. Thrombocytopenia induced by low-dose subcutaneous heparin. Lancet. 1978 Feb 25;1(8061):444–444. doi: 10.1016/s0140-6736(78)91234-5. [DOI] [PubMed] [Google Scholar]
  29. Mason E. E., Gordy D. D., Chernigoy F. A., Printen K. J. Fatty acid toxicity. Surg Gynecol Obstet. 1971 Dec;133(6):992–998. [PubMed] [Google Scholar]
  30. Mims J. A., Sarji K. E., Kleinfelder J. S., Eurenius K. Heparin-induced platelet aggregation in burn patients. Thromb Res. 1977 Feb;10(2):291–299. doi: 10.1016/0049-3848(77)90010-x. [DOI] [PubMed] [Google Scholar]
  31. Nalbandian R. M., Beller F. K., Kamp A. K., Henry R. L., Wolf P. L. Coumarin necrosis of skin treated successfully with heparin. Obstet Gynecol. 1971 Sep;38(3):395–399. [PubMed] [Google Scholar]
  32. Natelson E. A., Lynch E. C., Alfrey C. P., Jr, Gross J. B. Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy. Ann Intern Med. 1969 Dec;71(6):1121–1125. doi: 10.7326/0003-4819-71-6-1121. [DOI] [PubMed] [Google Scholar]
  33. O'Brien J. R. Heparin and platelets. Curr Ther Res Clin Exp. 1975 Jul;18(1 PT1):79–90. [PubMed] [Google Scholar]
  34. O'Toole R. D. Letter: Heparin: adverse reaction. Ann Intern Med. 1973 Nov;79(5):759–759. doi: 10.7326/0003-4819-79-5-759_1. [DOI] [PubMed] [Google Scholar]
  35. Pachter H. L., Riles T. S. Low dose heparin: bleeding and wound complications in the surgical patient. A prospective randomized study. Ann Surg. 1977 Dec;186(6):669–674. doi: 10.1097/00000658-197712000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet. 1975 Jul 12;2(7924):45–51. [PubMed] [Google Scholar]
  37. Printen K. J., Paulk S. C., Liebschutz D., Mason E. E. Differential free fatty acid response to heparin in diabetics. Br J Surg. 1974 Mar;61(3):183–184. doi: 10.1002/bjs.1800610304. [DOI] [PubMed] [Google Scholar]
  38. RAJKA G., SKOG E. On the question of heparin hypersensitivity. Acta Derm Venereol. 1962;42:27–34. [PubMed] [Google Scholar]
  39. ROBERTS B., ROSATO F. E., ROSATO E. F. HEPARIN--A CAUSE OF ARTERIAL EMBOLI? Surgery. 1964 Jun;55:803–808. [PubMed] [Google Scholar]
  40. Rhodes G. R., Dixon R. H., Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet. 1973 Mar;136(3):409–416. [PubMed] [Google Scholar]
  41. Rhodes G. R., Dixon R. H., Silver D. Heparin induced thrombocytopenia: eight cases with thrombotic-hemorrhagic complications. Ann Surg. 1977 Dec;186(6):752–758. doi: 10.1097/00000658-197712000-00017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rosenberg R. D. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975 Jan 16;292(3):146–151. doi: 10.1056/NEJM197501162920307. [DOI] [PubMed] [Google Scholar]
  43. Rutstein D. D., Castelli W. P., Nickerson R. J. Heparin and human lipid metabolism. Lancet. 1969 May 17;1(7603):1003–1008. doi: 10.1016/s0140-6736(69)91801-7. [DOI] [PubMed] [Google Scholar]
  44. Sagar S., Massey J., Sanderson J. M. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br Med J. 1975 Nov 1;4(5991):257–259. doi: 10.1136/bmj.4.5991.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Shanberge J. N., Kambayashi J., Nakagawa M. The interaction of platelets with a tritium-labelled heparin. Thromb Res. 1976 Dec;9(6):595–609. doi: 10.1016/0049-3848(76)90107-9. [DOI] [PubMed] [Google Scholar]
  46. Spector A. A., Hoak J. C., Warner E. D., Fry G. L. Utilization of long-chain free fatty acids by human platelets. J Clin Invest. 1970 Aug;49(8):1489–1496. doi: 10.1172/JCI106366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Spracklen F. H., Model D. G., Besterman E. M. The dangers of intermitten intravenous heparin therapy. Postgrad Med J. 1966 Nov;42(493):724–726. doi: 10.1136/pgmj.42.493.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. TURCOTTE J. G., KRAFT R. O., FRY W. J. HEPARIN REACTIONS IN PATIENTS WITH VASCULAR DISEASE. Arch Surg. 1965 Mar;90:375–379. doi: 10.1001/archsurg.1965.01320090053012. [DOI] [PubMed] [Google Scholar]
  49. Thomson C., Forbes C. D., Prentice C. R. The potentiation of platelet aggregation and adhesion by heparin in vitro and in vivo. Clin Sci Mol Med. 1973 Oct;45(4):485–494. doi: 10.1042/cs0450485. [DOI] [PubMed] [Google Scholar]
  50. WEISMANN R. E., TOBIN R. W. Arterial embolism occurring during systemic heparin therapy. AMA Arch Surg. 1958 Feb;76(2):219–227. doi: 10.1001/archsurg.1958.01280200041005. [DOI] [PubMed] [Google Scholar]
  51. Wahl T. O., Lipschitz D. A., Stechschulte D. J. Thrombocytopenia associated with antiheparin antibody. JAMA. 1978 Dec 1;240(23):2560–2562. [PubMed] [Google Scholar]
  52. Wu K. K. Platelet hyperaggregability and thrombosis in patients with thrombocythemia. Ann Intern Med. 1978 Jan;88(1):7–11. doi: 10.7326/0003-4819-88-1-7. [DOI] [PubMed] [Google Scholar]
  53. Zucker M. B. Heparin and platelet function. Fed Proc. 1977 Jan;36(1):47–49. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES